Medicare will move ostomy supplies to eight national contracts in 2028. Survivors and clinicians say a poor fit can lead to leaks, infection and hospital stays.
|Articles|September 18, 2013
- Fall 2013
- Volume 12
- Issue 3
Critical Mass Annual Conference
Author(s)Jon Garinn
Critical Mass's young adult survivor conference, "Connecting the Dots," kicks off in November.
Advertisement
“Connecting the Dots,” a conference dedicated to the needs of adolescents and young adults (AYAs) with cancer, will be taking place from Nov. 6 to 8 at the Renaissance Hotel in Cleveland, Ohio. Sponsored by Critical Mass, an alliance of nonprofit organizations, government agencies, research institutions and others, the conference will enable participants to discuss issues including re-entry into school or the workforce, insurance coverage, infertility as a result of treatment, neuro-cognitive effects and secondary malignancies. For more details, visit
Articles in this issue
about 13 years ago
Lung Cancer Video Touches on Emotions and Supportabout 13 years ago
Triple-Negative Breast Cancer: Divide and Conquerabout 13 years ago
Future Frontier: Fighting Cancer at the Genetic Levelabout 13 years ago
Second Chance: When Grandparents Become the Caregiversabout 13 years ago
Supreme Court Votes Against Human Gene Patentsabout 13 years ago
Documentary About Cancer Plannedabout 13 years ago
Superfoods Study Keeps More Men on Active Surveillanceabout 13 years ago
HPV Infections Plummet with Vaccineabout 13 years ago
DCA Claims Don’t Tell Whole StoryAdvertisement
Related to this article
An experimental treatment has kept one patient with heavily pretreated hairy cell leukemia free of detectable disease for more than two years, raising questions about whether CAR T-cell therapy could offer a path toward a cure.
The National Comprehensive Cancer Network released its first patient guideline written for caregivers on Oct. 27, 2026. The free guide covers emotional support, money, legal questions, medical tasks and caregivers' own well-being.
Three phase 3 trials presented at the 2026 ESMO Congress looked closely at swallowing, daily functioning and blood counts in throat, kidney and colorectal cancer. Here is what they found about living well during and after treatment.
New research found that nearly 1 in 5 second-level appeals for denied cancer medications under Medicare Part D were successful, raising questions about how insurers make coverage decisions and what patients can do when their treatment is denied.
Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, recurrence and life after treatment begins.
A national survey study of about 200,000 adults, published in Supportive Care in Cancer, found that people caring for someone with cancer had 89% higher odds of frequent mental distress than people who were not caregivers.
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ESMO 2026 That Patients Should Know
2
3 Quality-of-Life Results From ESMO 2026 Patients Should Know
3
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
4
What New KRAS Drug Data From ESMO 2026 Mean for Patients
5